Established breast and/or ovarian cancer genes were included, at the time mainly BRCA1, BRCA2 and a few syndrome genes, but also a long list of candidate genes for which rare alleles could potentially be associated with increased risk of developing breast cancer based on, for example, their functional role or published associations. This evidence concerns the gene BRCA1 and breast cancer.